TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms

OBJECTIVE: Hepatocellular carcinoma (HCC) is a prevalent and aggressive cancer usually arising on a background of chronic liver injury involving inflammatory and hepatic regenerative processes. The triggering receptor expressed on myeloid cells 2 (TREM-2) is predominantly expressed in hepatic non-pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Esparza-Baquer, Aitor, Labiano, Ibone, Sharif, Omar, Agirre-Lizaso, Aloña, Oakley, Fiona, Rodrigues, Pedro M, Zhuravleva, Ekaterina, O'Rourke, Colm J, Hijona, Elizabeth, Jimenez-Agüero, Raul, Riaño, Ioana, Landa, Ana, La Casta, Adelaida, Zaki, Marco Y W, Munoz-Garrido, Patricia, Azkargorta, Mikel, Elortza, Felix, Vogel, Andrea, Schabbauer, Gernot, Aspichueta, Patricia, Andersen, Jesper B, Knapp, Sylvia, Mann, Derek A, Bujanda, Luis, Banales, Jesus Maria, Perugorria, Maria Jesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223629/
https://www.ncbi.nlm.nih.gov/pubmed/32907830
http://dx.doi.org/10.1136/gutjnl-2019-319227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223629/
https://www.ncbi.nlm.nih.gov/pubmed/32907830
http://dx.doi.org/10.1136/gutjnl-2019-319227

Ejemplares similares